Quick Search

 

 


 

 

Result Summary for S3A174

Result Summary
Protocol ID: S3A174
Clinical Study ID: S3A174
Official Title: A dose-proportionality study of ondansetron administered as a single oral dose (tablet) to healthy male volunteers.
Phase: Phase 1
Study Indications or Diseases:
  • Nausea and Vomiting
Generic Name: ondansetron
Trade/Product Name: zofran;zofran
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.